ClinicalTrials.Veeva

Menu

Virtual Reality for Pediatric Palliative Care Team (PPCVR)

U

University of Padua

Status

Completed

Conditions

Occupational Stress

Treatments

Device: visor

Study type

Interventional

Funder types

Other

Identifiers

NCT06247618
ppcVirtualReality

Details and patient eligibility

About

Is virtual reality a useful and usable tool to improve the psychological well-being of PPC operators? study primary obtv: assessment of occupational psychological well-being (divided into stress, depression, anxiety and risk of burnout) in the population of health professionals working in pediatric palliative care; verify if the virtual reality tool leads to an improvement change at the level of the investigated items (feasibility study). The treatment will have a duration of 4 weeks, with the execution of two sessions per week with the use of a viewer positioned on the head that allows users to navigate and interact in real time with a three-dimensional (3D) environment At time zero (T0), the participants will be administered, shortly before the application of virtual reality, the Mini-Z survey 2.0 questionnaires (the single item burnout question), Depression Anxiety Stress Scales 21 (DASS-21), and a demographic questionnaire (gender, age, profession, shift work, years of work in PPCs). At the end of the compilation, two vision treatments will follow, which will take place three to four days apart.

At time T1 (second week) and time T2 (third week) the DASS-21 will initially be administered followed by two weekly treatments with a visor. At the end (T3) the compilation of both tests (Mini-Z survey 2.0-the single item burnout question and the DASS-21) will be repeated following the last two applications of the viewer.

Enrollment

27 patients

Sex

All

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • work within the pediatric hospice of Padua
  • Absence of neurological pathologies
  • personnel who actively engage in membership/participation during all 4 weeks of the project

Exclusion criteria

  • Subject do not sign written consent

Trial design

Primary purpose

Treatment

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

27 participants in 1 patient group

Virtual reality
Experimental group
Treatment:
Device: visor

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems